Our Team

The core 3E team has more than 10 years of healthcare investment experience and industry expertise in pharmaceutical and biotech.

Join Us
← View Team

Scott Smith

Dr. Scott Smith is the President of BioAtla, a San Diego biotech company that develops novel monoclonal antibody and cell-based therapeutics. Dr. Smith was the former President & COO of Celgene, and board member of Apexigen, Refuge, Truimvira, and Springbank.